Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTHRACYCLINES' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 490 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Torkkell, S; Kunnari, T; Palmu, K; Mantsala, P; Hakala, J; Ylihonko, K
      The entire nogalamycin biosynthetic gene cluster of Streptomyces nogalater: characterization of a 20-kb DNA region and generation of hybrid structures

      MOLECULAR GENETICS AND GENOMICS
    2. Zagotto, G; Gatto, B; Moro, S; Sissi, C; Palumbo, M
      Anthracyclines: recent developments in their separation and quantitation

      JOURNAL OF CHROMATOGRAPHY B
    3. Loadman, PM; Calabrese, CR
      Separation methods for anthraquinone related anti-cancer drugs

      JOURNAL OF CHROMATOGRAPHY B
    4. Bellott, R; Pouna, P; Robert, J
      Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome

      JOURNAL OF CHROMATOGRAPHY B
    5. Allen, J; Thomson, JDR; Lewis, IJ; Gibbs, JL
      Mitral regurgitation after anthracycline treatment for childhood malignancy

      HEART
    6. Teodori, E; Dei, S; Garnier-Suillerot, A; Quidu, P; Scapecchi, S; Budriesi, R
      Structure-activity relationship studies on the potent multidrug resistance(MDR) modulator 2-(3,4-dimethoxyphenyl)-2-(methylethyl)-5-[(anthr-9-yl)methylamino]pentanenitrile (MM 36)

      MEDICINAL CHEMISTRY RESEARCH
    7. Aviles, A; Diaz-Maqueo, JC; Garcia, EL; Talavera, A; Huerta-Guzman, J; Neri, N
      Late lethal events in patients with diffuse large B cell lymphoma: A review of 714 patients treated in a single centre

      LEUKEMIA & LYMPHOMA
    8. Michieli, M; Michelutti, A; Damiani, D; Ermacora, A; Masolini, P; Stocchi, R; Russo, D
      Amifostine does not inhibit the toxic effects of Anthracycline derivates or Mitoxantrone on MDR tumor cell lines

      LEUKEMIA & LYMPHOMA
    9. Colombo, P; Gunnarsson, K; Iatropoulos, M; Brughera, M
      Toxicological testing of cytotoxic drugs (Review)

      INTERNATIONAL JOURNAL OF ONCOLOGY
    10. Dei, S; Teodori, E; Garnier-Suillerot, A; Gualtieri, F; Scapecchi, S; Budriesi, R; Chiarini, A
      Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative

      BIOORGANIC & MEDICINAL CHEMISTRY
    11. Gonzalez-Paz, O; Polizzi, D; De Cesare, M; Zunino, F; Bigioni, M; Maggi, CA; Manzini, S; Pratesi, G
      Tissue distribution, antitumour activity and in vivo apoptosis induction by MEN10755 in nude mice

      EUROPEAN JOURNAL OF CANCER
    12. Hara, J; Park, YD; Yoshioka, A; Yumura-Yagi, K; Koudera, U; Hosoi, G; Sako, M; Kosaka, Y; Sano, K; Misu, H; Mabuchi, O; Aoyagi, N; Yamamoto, M; Tawa, A; Miyata, H; Tanaka, H; Kikkawa, M; Shimodera, M; Kawa-Ha, K
      Intensification of chemotherapy using block therapies as consolidation andreinduction therapies for acute lymphoblastic leukemia during childhood

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    13. Tulpule, A; Rarick, MU; Kolitz, J; Bernstein, J; Myers, A; Buchanan, LA; Espina, BM; Traynor, A; Letzer, J; Justice, GR; McDonald, D; Roberts, L; Boswell, W; Nathwani, B; Levine, AM
      Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    14. Smith, I
      Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab

      ANNALS OF ONCOLOGY
    15. Kirchmeier, MJ; Ishida, T; Chevrette, J; Allen, TM
      Correlations between the rate of intracellular release of endocytosed liposomal doxorubicin and cytotoxicity as determined by a new assay

      JOURNAL OF LIPOSOME RESEARCH
    16. Van Acker, FAA; Hulshof, JW; Haenen, GRMM; Menge, WMPB; van der Vijgh, WJF; Bast, A
      New synthetic flavonoids as potent protectors against doxorubicin-induced cardiotoxicity

      FREE RADICAL BIOLOGY AND MEDICINE
    17. Conte, P; Gennari, A; Guarneri, V; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E
      Epirubicin/taxane combinations in breast cancer: Experience from several Italian trials

      ONCOLOGY-NEW YORK
    18. Gabizon, AA
      Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy

      CANCER INVESTIGATION
    19. Orlandi, L; Bertoli, G; Abolafio, G; Daidone, MG; Zaffaroni, N
      Effects of liposome-entrapped annamycin in human breast cancer cells: Interference with cell cycle progression and induction of apoptosis

      JOURNAL OF CELLULAR BIOCHEMISTRY
    20. Trope, C; Kristensen, G; Kisic, J; Kaern, J
      Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    21. Loren, A; Eliasson, C; Josefson, M; Murty, KVGK; Kall, M; Abrahamsson, J; Abrahamsson, K
      Feasibility of quantitative determination of doxorubicin with surface-enhanced Raman spectroscopy

      JOURNAL OF RAMAN SPECTROSCOPY
    22. Donadio, M; Manzin, E; Berruti, A; Bottini, A; Gorzegno, G; Danese, S; DeFabiani, E; Sarobba, MG; Lorusso, V; Castiglione, F; Moro, G; Bertetto, O; Bumma, C; Dogliotti, L
      Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretrested metastatic breast cancer patients. A multicenter phase II trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    23. Della Torre, P; Podesta, A; Imondi, AR; Moneta, D; Sammartini, U; Arrigoni, C; Terron, A; Brughera, M
      PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    24. Serrone, L; Zeuli, M; Gamucci, T; Nardi, M; Cognetti, F
      A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissuesarcomas; a novel sequential schedule

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    25. Hauser, M; Gibson, BS; Wilson, N
      Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography

      EUROPEAN JOURNAL OF PEDIATRICS
    26. Boquete, AL; Roig, LV; Lopez, GA; Gude, R; Binda, MM; Gonzalez, AD; Ciocca, DR; Bonfil, RD
      Differential anthracycline sensitivity in two related human colon carcinoma cell lines expressing similar levels of P-glycoprotein

      CANCER LETTERS
    27. Heidenreich, A; von Knobloch, R; Hofmann, R
      Current status of cytotoxic chemotherapy in hormone refractory prostate cancer

      EUROPEAN UROLOGY
    28. Gaugg, M; Haslmayer, P; Jager, W; Thalhammer, T
      Influence of hypotonic stress on the biliary excretion of doxorubicin in Wistar and TR- rats

      ANTICANCER RESEARCH
    29. Burke, PJ; Koch, TH
      Doxorubicin-formaldehyde conjugate, Doxoform: Induction of apoptosis relative to doxorubicin

      ANTICANCER RESEARCH
    30. Rudra, PK; Krokan, HE
      Cell-specific enhancement of doxorubicin toxicity in human tumour cells bydocosahexaenoic acid

      ANTICANCER RESEARCH
    31. Lo, YL; Liu, FI; Yang, JM; Cherng, JY
      Reversal of multidrug resistance to epirubicin by cyclosporin a in liposomes or intralipid

      ANTICANCER RESEARCH
    32. Monneret, C
      Recent developments in the field of antitumour anthracyclines

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    33. Perez-Ruiz, T; Martinez-Lozano, C; Sanz, A; Bravo, E
      Simultaneous determination of doxorubicin, daunorubicin, and idarubicin bycapillary electrophoresis with laser-induced fluorescence detection

      ELECTROPHORESIS
    34. Vaksmann, G; Gutierrez, R; Duhamel, A; Nelken, B; Francart, C; Kouakam, C; Mazingue, F; Rey, C
      Signal-averaged electrocardiography in children with anthracycline-inducedcardiomyopathy

      PEDIATRIC CARDIOLOGY
    35. Jung, K; Reszka, R
      Mitochondria as subcellular targets for clinically useful anthracyclines

      ADVANCED DRUG DELIVERY REVIEWS
    36. Conte, PF; Gennari, A; Donati, S; Salvadori, B; Baldini, E; Bengala, C; Pazzagli, I; Orlandini, C; Danesi, R; Fogli, S; Del Tacca, M
      Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study

      BREAST CANCER RESEARCH AND TREATMENT
    37. Alba, E; Ribelles, N; Sevilla, I; Rueda, A; Alonso, L; Marquez, A; Ruiz, I; Miramon, J
      Adjuvant anthracycline therapy as a prognostic factor in metastatic breastcancer

      BREAST CANCER RESEARCH AND TREATMENT
    38. Iarussi, D; Galderisi, M; Ratti, G; Tedesco, MA; Indolfi, P; Casale, F; Di Tullio, MT; de Divitiis, O; Iacono, A
      Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood

      CLINICAL CARDIOLOGY
    39. Bossi, G; Lanzarini, L; Laudisa, ML; Klersy, C; Raisaro, A; Arico, M
      Echocardiographic evaluation of patients cured of childhood cancer: A single center study of 117 subjects who received anthracyclines

      MEDICAL AND PEDIATRIC ONCOLOGY
    40. Yasui, K; Wakabayashi, I; Negoro, M; Suehiro, A; Kakishita, E
      Daunorubicin inhibits gene expression of cyclooxygenase-2 in vascular smooth muscle cells

      THROMBOSIS RESEARCH
    41. Caballero, E; Longieras, N; Zausa, E; del Rey, B; Medarde, M; Tome, F
      Diels-Alder reactivity and some synthetic applications of (E)-1-(3-indolyl)-3-tert-butyldimethylsiloxy-1,3-butadienes

      TETRAHEDRON LETTERS
    42. Fountzilas, G; Papadimitriou, C; Aravantinos, G; Nicolaides, C; Stathopoulos, G; Bafaloukos, D; Kalofonos, H; Ekonomopoulos, T; Skarlos, D; Pavlidis, N; Dimopoulos, AM
      Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer

      ONCOLOGY
    43. Vetrivel, KS; Dharmalingam, K
      Isolation and characterization of stable mutants of Streptomyces peucetiusdefective in daunorubicin biosynthesis

      JOURNAL OF GENETICS
    44. Houba, PHJ; Boven, E; van der Meulen-Muileman, IH; Leenders, RGG; Scheeren, JW; Pinedo, HM; Haisma, HJ
      Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate

      INTERNATIONAL JOURNAL OF CANCER
    45. Sacco, G; Bigioni, M; Evangelista, S; Goso, C; Manzini, S; Maggi, CA
      Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat

      EUROPEAN JOURNAL OF PHARMACOLOGY
    46. Trouet, A; Passioukov, A; Van Derpoorten, K; Fernandez, AM; Abarca-Quinones, J; Baurain, R; Lobl, TJ; Oliyai, C; Shochat, D; Dubois, V
      Extracellularly tumor-activated prodrugs for the selective chemotherapy ofcancer: Application to doxorubicin and preliminary in vitro and in vivo studies

      CANCER RESEARCH
    47. Cortes, J; Estey, E; O'Brien, S; Giles, F; Shen, Y; Koller, C; Beran, M; Thomas, D; Keating, M; Kantarjian, H
      High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia

      CANCER
    48. Houba, PHJ; Boven, E; van der Meulen-Muileman, IH; Leenders, RGG; Scheeren, JW; Pinedo, HM; Haisma, HJ
      A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

      BRITISH JOURNAL OF CANCER
    49. Leonard, RCF
      Oval fluoropyrimidines among the new drugs for patients with metastatic breast cancer

      BRITISH JOURNAL OF CANCER
    50. Bigioni, M; Salvatore, C; Bullo, A; Bellarosa, D; Iafrate, E; Animati, F; Capranico, G; Goso, C; Maggi, CA; Pratesi, G; Zunino, F; Manzini, S
      A comparative study of cellular and molecular pharmacology of doxorubicin and MEN 10755, a disaccharide analogue

      BIOCHEMICAL PHARMACOLOGY
    51. Zunino, F; Pratesi, G; Perego, P
      Role of the sugar moiety in the pharmacological activity of anthracyclines: development of a novel series of disaccharide analogs

      BIOCHEMICAL PHARMACOLOGY
    52. Lachatre, F; Marquet, P; Ragot, S; Gaulier, JM; Cardot, P; Dupuy, JL
      Simultaneous determination of four anthracyclines and three metabolites inhuman serum by liquid chromatography-electrospray mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    53. Kantola, J; Kunnari, T; Hautala, A; Hakala, J; Ylihonko, K; Mantsala, P
      Elucidation of anthracyclinone biosynthesis by stepwise cloning of genes for anthracyclines from three different Streptomyces spp.

      MICROBIOLOGY-UK
    54. Mladosievicova, B; Foltinova, A; Petrasova, H; Hulin, I
      Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    55. Horenstein, MS; Vander Heide, RS; L'Ecuyer, TJ
      Molecular basis of anthracycline-induced cardiotoxicity and its prevention

      MOLECULAR GENETICS AND METABOLISM
    56. Eidenschink, AB; Schroter, G; Muller-Weihrich, S; Stern, H
      Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood

      CARDIOLOGY IN THE YOUNG
    57. Breda, M; Benedetti, MS; Battaglia, R; Castelli, MG; Poggesi, I; Spinelli, R; Hackett, AM; Dostert, P
      Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent

      PHARMACOLOGICAL RESEARCH
    58. Al-Shabanah, OA; El-Kashef, HA; Badary, OA; Al-Bekairi, AM; Elmazar, MMA
      Effect of streptozotocin-induced hyperglycaemia on intravenous pharmacokinetics and acute cardiotoxicity of doxorubicin in rats

      PHARMACOLOGICAL RESEARCH
    59. Giles, FJ; Wong, GC; Clark, SJ; Pierce, S; Kantarjian, HM; Keating, MJ
      Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemia

      LEUKEMIA & LYMPHOMA
    60. Kirschning, A; Chen, GW; Drager, G; Schuberth, I; Tietze, LF
      Syntheses and biological evaluation of new glyco-modified angucyclin-antibiotics

      BIOORGANIC & MEDICINAL CHEMISTRY
    61. Katsimbri, P; Bamias, A; Pavlidis, N
      Prevention of chemotherapy-induced alopecia using an effective scalp cooling system

      EUROPEAN JOURNAL OF CANCER
    62. Benderra, Z; Trussardi, A; Morjani, H; Villa, AM; Doglia, SM; Manfait, M
      Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein

      EUROPEAN JOURNAL OF CANCER
    63. Eksborg, S; Palm, C; Bjork, O
      A comparative pharmacokinetic study of doxorubicin and 4 '-epi-doxorubicinin children with acute lymphocytic leukemia using a limited sampling procedure

      ANTI-CANCER DRUGS
    64. Le Moyec, L; Legrand, O; Larue, V; Kawakami, M; Marie, JP; Calvo, F; Hantz, E; Taillandier, E
      Magnetic resonance spectroscopy of cellular lipid extracts from sensitive,resistant and reverting K562 cells and flow cytometry for investigating the P-glycoprotein function in resistance reversion

      NMR IN BIOMEDICINE
    65. Lehne, G; Morkrid, L; den Boer, M; Rugstad, HE
      Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP)

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    66. Gieseler, F; Clark, M; Stiebeling, K; Puschmann, M; Valsamas, S
      Induction of apoptosis by idarubicin: how important is the plasma peak?

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    67. Sheafor, SE; Couto, CG; Ward, H; Essinger, C; Nicol, SJ
      Clinical evaluation of methoximorpholino-doxorubicin (FCE 23762) in dogs with spontaneous malignancies

      JOURNAL OF VETERINARY INTERNAL MEDICINE
    68. Prestor, VV; Rakovec, P; Kozelj, M; Jereb, B
      Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    69. Massacesi, C; Bascioni, R; Cellerino, R; Scartozzi, M; Bracci, R; Alessandroni, P; Antognoli, S; Ciavattini, A; De Nictolis, M; Piga, A
      Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    70. Rossini, F; Verga, M; Pioltelli, P; Giltri, G; Sancassani, V; Pogliani, EM; Corneo, G
      Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens

      HAEMATOLOGICA
    71. Thomssen, C
      The role of anthracyclines in the adjuvant therapy of breast cancer

      ONKOLOGIE
    72. Kuhn, W
      The role of anthracyclines in the treatment of metastatic breast cancer

      ONKOLOGIE
    73. Mobus, V
      Experiences with Caelyx (R) in the treatment of metastatic breast cancer

      ONKOLOGIE
    74. du Bois, A
      Anthracyclines in ovarian cancer - Past, present and future

      ONKOLOGIE
    75. Brunetti, L; Orlando, G; Michelotto, B; Recinella, L; Ragazzoni, E; Vacca, M
      A possible prolactin-related adverse effect of certain antineoplastic anthracyclines

      TOXICOLOGY LETTERS
    76. Nony, P; Guastalla, JP; Rebattu, P; Landais, P; Lievre, M; Bontemps, L; Itti, P; Beaune, J; Andre-Fouet, X; Janier, M
      In vivo measurement of myocardial oxidative metabolism and blood flow doesnot show changes in cancer patients undergoing doxorubicin therapy

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    77. Pilger, A; Kohler, I; Stettner, H; Mader, RM; Rizovski, B; Terkola, R; Diem, E; Franz-Hainzl, E; Konnaris, C; Valic, E; Rudiger, HW
      Long-term monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to cytostatic drugs

      INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH
    78. Bandyopadhyay, C; Sur, KR; Patra, R; Sen, A
      Sodium naphthalenide-induced conversion of 3-methoxycarbonyl-4-oxo-4H-1-benzopyran into 4-hydroxy-3-salicyloylxanthone

      JOURNAL OF CHEMICAL RESEARCH-S
    79. Cullinane, C; Cutts, SM; Panousis, C; Phillips, DR
      Interstrand cross-linking by Adriamycin in nuclear and mitochondrial DNA of MCF-7 cells

      NUCLEIC ACIDS RESEARCH
    80. Lehmann, S; Isberg, B; Ljungman, P; Paul, C
      Cardiac systolic function before and after hematopoietic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    81. Nicolini, B; Balduzzi, A; Tagliabue, A; Longoni, D; Uderzo, C; Galli, MA
      Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation

      BONE MARROW TRANSPLANTATION
    82. Cividalli, A; Livdi, E; Ceciarelli, F; Piscitelli, M; Pasqualetti, P; Cruciani, G; Danesi, DT
      Hyperthermia and paclitaxel-epirubicin chemotherapy: enhanced cytotoxic effect in a murine mammary adenocarcinoma

      INTERNATIONAL JOURNAL OF HYPERTHERMIA
    83. Woessner, R; An, ZL; Li, XM; Hoffman, RM; Dix, R; Bitonti, A
      Comparison of three approaches to doxorubicin therapy: Free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826)

      ANTICANCER RESEARCH
    84. Simonsen, LE; Wahlby, U; Sandstrom, M; Freijs, A; Karlsson, MO
      Haematological toxicity following different dosing schedules of 5-fluorouracil and epirubicin in rats

      ANTICANCER RESEARCH
    85. Pagnini, U; Pacilio, C; Florio, S; Crispino, A; Claudio, PP; Giordano, A; Pagnini, G
      Medroxyprogesterone acetate increases anthracyclines uptake in chronic lymphatic leukemia cells: Role of nitric oxide and lipid peroxidation

      ANTICANCER RESEARCH
    86. Merlin, JL; Bour-Dill, C; Marchal, S; Ramacci, C; Poullain, MG; Giroux, B
      Modulation of daunorubicin cellular resistance by combination of P-glycoprotein blockers acting on drug efflux and intracellular drug sequestration in golgi vesicles

      CYTOMETRY
    87. Belloc, F; Belaud-Rotureau, MA; Lavignolle, V; Bascans, E; Braz-Pereira, E; Durrieu, F; Lacombe, F
      Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells

      CYTOMETRY
    88. Kuratsu, J; Arita, N; Kayama, T; Kubo, N; Mori, T; Sawamura, Y; Ushio, Y
      Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients

      JOURNAL OF NEURO-ONCOLOGY
    89. Cirillo, R; Sacco, G; Venturella, S; Brightwell, J; Giachetti, A; Manzini, S
      Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    90. Zargar, SJ; Rabbani, A
      The effects of daunomycin antibiotic on histone H-1, thermal denaturation and fluorescence spectroscopy studies

      INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
    91. Olson, RD; Li, XD; Palade, P; Shadle, SE; Mushlin, PS; Gambliel, HA; Fill, M; Boucek, RJ; Cusack, BJ
      Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    92. Platel, D; Pouna, P; Bonoron-Adele, S; Robert, J
      Preclinical evaluation of the cardiotoxicity of taxane-anthracycline combinations using the model of isolated perfused rat heart

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    93. Komatsu, K; Shigemori, H; Shiro, M; Kobayashi, J
      Revised stereochemistry and biosynthesis of seragakinone A

      TETRAHEDRON
    94. Emara, S; Morita, I; Tamura, K; Razee, S; Masujima, T; Mohamed, HA; El-Gizawy, SM; El-Rabbat, NA
      Effect of cyclodextrins on the stability of adriamycin, adriamycinol, adriamycinone and daunomycin

      TALANTA
    95. Castaing, M; Brouant, P; Loiseau, A; Santelli-Rouvier, C; Santelli, M; Alibert-Franco, S; Mahamoud, A; Barbe, J
      Membrane permeation by multidrug-resistance-modulators and non-modulators:Effects of hydrophobicity and electric charge

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    96. Weinstein, DM; Mihm, MJ; Bauer, JA
      Cardiac peroxynitrite formation and left ventricular dysfunction followingdoxorubicin treatment in mice

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    97. Tunggal, JK; Melo, T; Ballinger, JR; Tannock, IF
      The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers

      INTERNATIONAL JOURNAL OF CANCER
    98. Calcabrini, A; Meschini, S; Stringaro, A; Cianfriglia, M; Arancia, G; Molinari, A
      Detection of P-glycoprotein in the nuclear envelope of multidrug resistantcells

      HISTOCHEMICAL JOURNAL
    99. Konecny, G; Pegram, M; Untch, M; Thomssen, C; Janicke, F; Hepp, H; Slamon, DJ
      HER-2/neu as a predictive marker in breast cancer

      GEBURTSHILFE UND FRAUENHEILKUNDE
    100. Wielinga, PR; Westerhoff, HV; Lankelma, J
      The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells

      EUROPEAN JOURNAL OF BIOCHEMISTRY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 21:35:48